[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Urological Cancer Therapeutics Drugs Market Research Report 2017

December 2017 | 117 pages | ID: G39188D49F6EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Urological Cancer Therapeutics Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Urological Cancer Therapeutics Drugs in these regions, from 2012 to 2022 (forecast), covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Global Urological Cancer Therapeutics Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
  • Novartis
  • Pfizer
  • Johnson & Johnson
  • AstraZeneca
  • Astellas
  • Bristol-Myers Squibb
  • Abbott Laboratories
  • Celgene Corporation
  • Dendreon Corporation
  • Ferring Pharmaceuticals
  • GlaxoSmithKline plc
  • Indevus Pharmaceuticals Inc
  • Ipsen
  • Roche Healthcare
  • Sanofi S.A.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Xofigo (radium Ra 223 dichloride)
  • Jevtana (cabazitaxel)
  • Inlyta (axitinib)
  • Votrient (pazopanib hydrochloride)
  • Sutent (sunitinib malate)
  • Zytiga (abiraterone acetate)
  • Xtandi (enzalutamide)
  • Opdivo (nivolumab)
  • Provenge (sipuleucel-T)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
  • Hospital
  • Medical Research Laboratory
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Urological Cancer Therapeutics Drugs Market Research Report 2017

1 UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs
1.2 Urological Cancer Therapeutics Drugs Segment by Type (Product Category)
  1.2.1 Global Urological Cancer Therapeutics Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Urological Cancer Therapeutics Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Xofigo (radium Ra 223 dichloride)
  1.2.4 Jevtana (cabazitaxel)
  1.2.5 Inlyta (axitinib)
  1.2.6 Votrient (pazopanib hydrochloride)
  1.2.7 Sutent (sunitinib malate)
  1.2.8 Zytiga (abiraterone acetate)
  1.2.9 Xtandi (enzalutamide)
  1.2.10 Opdivo (nivolumab)
  1.2.11 Provenge (sipuleucel-T)
1.3 Global Urological Cancer Therapeutics Drugs Segment by Application
  1.3.1 Urological Cancer Therapeutics Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Research Laboratory
  1.3.4 Others
1.4 Global Urological Cancer Therapeutics Drugs Market by Region (2012-2022)
  1.4.1 Global Urological Cancer Therapeutics Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Urological Cancer Therapeutics Drugs (2012-2022)
  1.5.1 Global Urological Cancer Therapeutics Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Urological Cancer Therapeutics Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Urological Cancer Therapeutics Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Urological Cancer Therapeutics Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Urological Cancer Therapeutics Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Urological Cancer Therapeutics Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Urological Cancer Therapeutics Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Urological Cancer Therapeutics Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Urological Cancer Therapeutics Drugs Market Competitive Situation and Trends
  2.5.1 Urological Cancer Therapeutics Drugs Market Concentration Rate
  2.5.2 Urological Cancer Therapeutics Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Urological Cancer Therapeutics Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Urological Cancer Therapeutics Drugs Production and Market Share by Region (2012-2017)
3.3 Global Urological Cancer Therapeutics Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Urological Cancer Therapeutics Drugs Consumption by Region (2012-2017)
4.2 North America Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Urological Cancer Therapeutics Drugs Production and Market Share by Type (2012-2017)
5.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Urological Cancer Therapeutics Drugs Price by Type (2012-2017)
5.4 Global Urological Cancer Therapeutics Drugs Production Growth by Type (2012-2017)

6 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Urological Cancer Therapeutics Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Urological Cancer Therapeutics Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novartis
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Novartis Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Pfizer
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Pfizer Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 AstraZeneca
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Astellas
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Astellas Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Bristol-Myers Squibb
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Abbott Laboratories
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Celgene Corporation
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Dendreon Corporation
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Ferring Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 GlaxoSmithKline plc
7.12 Indevus Pharmaceuticals Inc
7.13 Ipsen
7.14 Roche Healthcare
7.15 Sanofi S.A.

8 UROLOGICAL CANCER THERAPEUTICS DRUGS MANUFACTURING COST ANALYSIS

8.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Urological Cancer Therapeutics Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET FORECAST (2017-2022)

12.1 Global Urological Cancer Therapeutics Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Urological Cancer Therapeutics Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Urological Cancer Therapeutics Drugs Price and Trend Forecast (2017-2022)
12.2 Global Urological Cancer Therapeutics Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Urological Cancer Therapeutics Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Urological Cancer Therapeutics Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Urological Cancer Therapeutics Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Urological Cancer Therapeutics Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Urological Cancer Therapeutics Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Urological Cancer Therapeutics Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Urological Cancer Therapeutics Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Urological Cancer Therapeutics Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Urological Cancer Therapeutics Drugs
Figure Global Urological Cancer Therapeutics Drugs Production (Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Xofigo (radium Ra 223 dichloride)
Table Major Manufacturers of Xofigo (radium Ra 223 dichloride)
Figure Product Picture of Jevtana (cabazitaxel)
Table Major Manufacturers of Jevtana (cabazitaxel)
Figure Product Picture of Inlyta (axitinib)
Table Major Manufacturers of Inlyta (axitinib)
Figure Product Picture of Votrient (pazopanib hydrochloride)
Table Major Manufacturers of Votrient (pazopanib hydrochloride)
Figure Product Picture of Sutent (sunitinib malate)
Table Major Manufacturers of Sutent (sunitinib malate)
Figure Product Picture of Zytiga (abiraterone acetate)
Table Major Manufacturers of Zytiga (abiraterone acetate)
Figure Product Picture of Xtandi (enzalutamide)
Table Major Manufacturers of Xtandi (enzalutamide)
Figure Product Picture of Opdivo (nivolumab)
Table Major Manufacturers of Opdivo (nivolumab)
Figure Product Picture of Provenge (sipuleucel-T)
Table Major Manufacturers of Provenge (sipuleucel-T)
Figure Global Urological Cancer Therapeutics Drugs Consumption (Units) by Applications (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Research Laboratory Examples
Table Key Downstream Customer in Medical Research Laboratory
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Urological Cancer Therapeutics Drugs Market Size (Million USD), Comparison (Units) and CAGR (%) by Regions (2012-2022)
Figure North America Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Capacity, Production (Units) Status and Outlook (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Major Players Product Capacity (Units) (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Capacity (Units) of Key Manufacturers (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Capacity (Units) of Key Manufacturers in 2016
Figure Global Urological Cancer Therapeutics Drugs Capacity (Units) of Key Manufacturers in 2017
Figure Global Urological Cancer Therapeutics Drugs Major Players Product Production (Units) (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Production (Units) of Key Manufacturers (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Urological Cancer Therapeutics Drugs Production Share by Manufacturers
Figure 2017 Urological Cancer Therapeutics Drugs Production Share by Manufacturers
Figure Global Urological Cancer Therapeutics Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers
Table 2017 Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers
Table Global Market Urological Cancer Therapeutics Drugs Average Price (K USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Urological Cancer Therapeutics Drugs Average Price (K USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Urological Cancer Therapeutics Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Urological Cancer Therapeutics Drugs Product Category
Figure Urological Cancer Therapeutics Drugs Market Share of Top 3 Manufacturers
Figure Urological Cancer Therapeutics Drugs Market Share of Top 5 Manufacturers
Table Global Urological Cancer Therapeutics Drugs Capacity (Units) by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Capacity Market Share by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Urological Cancer Therapeutics Drugs Capacity Market Share by Region
Table Global Urological Cancer Therapeutics Drugs Production by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Production (Units) by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Urological Cancer Therapeutics Drugs Production Market Share by Region
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region
Figure Global Urological Cancer Therapeutics Drugs Capacity, Production (Units) and Growth Rate (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table North America Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Europe Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table China Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table India Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Consumption (Units) Market by Region (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Consumption Market Share by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Urological Cancer Therapeutics Drugs Consumption (Units) Market Share by Region
Table North America Urological Cancer Therapeutics Drugs Production, Consumption, Import & Export (Units) (2012-2017)
Table Europe Urological Cancer Therapeutics Drugs Production, Consumption, Import & Export (Units) (2012-2017)
Table China Urological Cancer Therapeutics Drugs Production, Consumption, Import & Export (Units) (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Production, Consumption, Import & Export (Units) (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Import & Export (Units) (2012-2017)
Table India Urological Cancer Therapeutics Drugs Production, Consumption, Import & Export (Units) (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Production (Units) by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Urological Cancer Therapeutics Drugs by Type
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Urological Cancer Therapeutics Drugs by Type
Table Global Urological Cancer Therapeutics Drugs Price (K USD/Unit) by Type (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Production Growth by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Consumption (Units) by Application (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Consumption Market Share by Application (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Consumption Market Share by Application in 2016
Table Global Urological Cancer Therapeutics Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Consumption Growth Rate by Application (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Astellas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Dendreon Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production Growth Rate (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production Market Share (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs
Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure Urological Cancer Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
Table Major Buyers of Urological Cancer Therapeutics Drugs
Table Distributors/Traders List
Figure Global Urological Cancer Therapeutics Drugs Capacity, Production (Units) and Growth Rate Forecast (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Production (Units) Forecast by Region (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Consumption (Units) Forecast by Region (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Urological Cancer Therapeutics Drugs Production (Units) and Growth Rate Forecast (2017-2022)
Figure North America Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure Europe Urological Cancer Therapeutics Drugs Production (Units) and Growth Rate Forecast (2017-2022)
Figure Europe Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure China Urological Cancer Therapeutics Drugs Production (Units) and Growth Rate Forecast (2017-2022)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure Japan Urological Cancer Therapeutics Drugs Production (Units) and Growth Rate Forecast (2017-2022)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Production (Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure India Urological Cancer Therapeutics Drugs Production (Units) and Growth Rate Forecast (2017-2022)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Production (Units) Forecast by Type (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Production (Units) Forecast by Type (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Price Forecast by Type (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Consumption (Units) Forecast by Application (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Consumption (Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


More Publications